TrialBritish journal of cancer2016

Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab.

Cong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.